Published in Int Surg on September 24, 1982
Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol (2003) 2.28
Tetanus toxin. Microbiol Rev (1979) 2.25
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol (2013) 2.09
Adjuvants--a balance between toxicity and adjuvanticity. Vaccine (1993) 1.86
Germ cell tumors of the mediastinum. A 30-year experience. Cancer (1993) 1.86
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors. J Thorac Cardiovasc Surg (1991) 1.72
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol (2001) 1.62
[Perineal incisional hernia following rectal resection. Diagnostic and management]. Ann Chir (2003) 1.57
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun (1984) 1.45
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant (1993) 1.39
[Subclinical identification of cancer of the breast. Radiologic progress, proposition for treatment]. Chirurgie (1989) 1.39
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38
[Changing attitudes on the surgical treatment of urogenital prolapse: birth of the tension-free vaginal mesh]. J Gynecol Obstet Biol Reprod (Paris) (2004) 1.38
An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J Neurochem (1977) 1.26
Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol (2000) 1.24
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology (1996) 1.23
Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer (1985) 1.20
Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.20
Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother (1998) 1.16
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene (2010) 1.15
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol (2003) 1.13
Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg (1994) 1.08
Papain-derived fragment IIc of tetanus toxin: its binding to isolated synaptic membranes and retrograde axonal transport. Brain Res (1981) 1.07
Chemical characterization of tetanus toxin and toxoid. Amino acid composition, number of SH and S-S groups and N-terminal amino acid. Eur J Biochem (1970) 1.04
Experimental modification of postnatal cerebellar granule cell migration in vitro. Brain Res (1986) 1.04
Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet (1986) 1.02
MetaHox gene clusters. J Exp Zool (2000) 1.01
Involvement of gangliosides in rabies virus infection. J Gen Virol (1986) 1.01
[Glucagonomas. Clinical, biological, anatomopathological and therapeutic aspects (general review of 130 cases]. Gastroenterol Clin Biol (1982) 1.01
Extensive facial vascular malformations and haemangiomas: a review of the literature and case reports. J Craniomaxillofac Surg (1997) 1.00
Primary dedifferentiated liposarcoma of the colon: a case report. Gastroenterol Clin Biol (2009) 1.00
[Production and purification of tetanus toxin]. Ann Inst Pasteur (Paris) (1969) 1.00
Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.99
Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol (1999) 0.97
[Amebic liver abscess in pregnant women. Apropos of 2 cases simulating pulmonary embolism]. Bull Mem Soc Med Hop Paris (1968) 0.97
Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. Gut (1985) 0.96
HgC12 induces T and B cells to proliferate and differentiate in BN rats. Clin Exp Immunol (1988) 0.96
[Study of blood lymphocytes in systemic lupus erythematosus]. Pathol Biol (Paris) (1971) 0.96
Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine (1998) 0.95
Monoclonal antibodies against tetanus toxin and toxoid. Med Microbiol Immunol (1983) 0.95
[Presence of virus particles in organs of the NZB mouse]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.95
[TVT Secur: more and more minimally invasive. Preliminary prospective study of 110 cases]. J Gynecol Obstet Biol Reprod (Paris) (2008) 0.95
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol (1999) 0.94
Use of the B-IIb tetanus toxin derived fragment as a specific neuropharmacological transport agent. Brain Res (1980) 0.94
Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev (2003) 0.94
Naturally acquired antibodies to tetanus toxin in humans and animals from the galápagos islands. J Infect Dis (1983) 0.94
Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology (2000) 0.93
[Immunological and biological study of subunits of tetanus toxin]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.93
Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol (2001) 0.93
Classical and nerve-sparing radical hysterectomy: an evaluation of the risk of injury to the autonomous pelvic nerves. Surg Radiol Anat (2003) 0.92
On the structure of tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.92
[Presence of viral particles in the organs of the NZB mouse]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.92
Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis. Liver (1998) 0.92
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. Ann Rheum Dis (2007) 0.92
De novo t(X;21)(q28;q11) in a girl with phenotypic features of Williams-Beuren syndrome. J Med Genet (1992) 0.91
Involvement of alpha-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment. Biomed Pharmacother (1994) 0.91
Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroenterology (1995) 0.91
Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. J Clin Invest (1985) 0.91
[Purification and properties of streptococcal erythrogenic toxin]. Ann Inst Pasteur (Paris) (1968) 0.91
Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy (1987) 0.91
Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Hepatology (1996) 0.90
[TVT Secur: prospective study and follow up at 1 year about 154 patients]. J Gynecol Obstet Biol Reprod (Paris) (2009) 0.89
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.89
Blood lymphocytes in acute lymphoid leukaemia in remission and in relapse. Predictive value of electrophoretic mobility and refringence. Biomedicine (1975) 0.89
Tat toxoid as a component of a preventive vaccine in seronegative subjects. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.89
Generation of high specificity of effect through low-specificity binding of proteins to DNA. FEBS Lett (1988) 0.89
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study. Ann Oncol (2014) 0.88
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy. Biomed Pharmacother (1999) 0.88
Neurotropism of rabies virus. An in vitro study. J Neuropathol Exp Neurol (1983) 0.88
Preparation of conjugates using two tetanus toxin derived fragments: their binding to gangliosides and isolated synaptic membranes and their immunological properties. Toxicon (1980) 0.87
[The regression of mammary glands at the end of lactation. II. Electron microscopic study]. Z Zellforsch Mikrosk Anat (1967) 0.87
[Mechanism of detoxification by formol]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.87
[Submaxillary gland of the mouse and the rat. An electron microscopic study]. Z Zellforsch Mikrosk Anat (1965) 0.87
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategy. J Acquir Immune Defic Syndr (1992) 0.87
Salivary trichomoniasis. A case report of infestation of a submaxillary gland by Trichomonas tenax. Arch Pathol Lab Med (1995) 0.87
Treatment of intraosseous high flow arteriovenous malformation of the mandible by temporary segmental ostectomy for extracorporal tumour resection: a case report. J Craniomaxillofac Surg (1996) 0.86
Immunologic approaches to blockade of the renin-angiotensin system: a review. Am Heart J (1989) 0.86
Active immunization against renin in normotensive marmoset. Proc Natl Acad Sci U S A (1987) 0.86
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma. Ann Oncol (2001) 0.86
Immunochemistry of tetanus toxin. The nitration of tyrosyl residues in tetanus toxin. Eur J Biochem (1973) 0.86
Selective increased tissue histamine levels in tumour-bearing rodents. Agents Actions (1983) 0.86
[Autoimmune hepatitis induced by fibrates]. Gastroenterol Clin Biol (1998) 0.86
Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study. Int Urogynecol J (2013) 0.86
ATP release from pure cholinergic synaptosomes is not blocked by tetanus toxin. FEBS Lett (1987) 0.85
Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin. Circulation (1990) 0.85
Oncoplastic conservative treatment for breast cancer (part 3): techniques for the upper quadrants. J Visc Surg (2010) 0.85
Detection and localization of renin messenger RNA in human pathologic tissues using in situ hybridization. Am J Pathol (1988) 0.84
Human T cell clones specific for tetanus toxoid: characterization of antigen specificity and HLA restriction. Eur J Immunol (1982) 0.84
[Adenoid cystic carcinoma (cylindroma) of the uterine cervix. Histology, immunohistochemistry, ultrastructure in a case, with review of the medical literature]. Arch Anat Cytol Pathol (1994) 0.84
[Synthesis and reabsorption of proteins in the mammary gland during stasis, autoradiographic and electron microscopic study]. Z Zellforsch Mikrosk Anat (1966) 0.84
[A case of acute thyrotoxicosis with flabby quadriplegia and paralysis of the pharyngo-laryngeal junction. Favorable course after thyroidectomy]. Presse Med (1970) 0.84
Pneumococcal vaccination of elderly individuals. Vaccine (1991) 0.83